GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Provexis PLC (LSE:PXS) » Definitions » Other Stockholders Equity

Provexis (LSE:PXS) Other Stockholders Equity : £6.60 Mil (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Provexis Other Stockholders Equity?

Provexis's Other Stockholders Equity for the quarter that ended in Mar. 2024 was £6.60 Mil.

Provexis's quarterly Other Stockholders Equity declined from Mar. 2023 (£6.60 Mil) to Sep. 2023 (£6.60 Mil) but then increased from Sep. 2023 (£6.60 Mil) to Mar. 2024 (£6.60 Mil).

Provexis's annual Other Stockholders Equity increased from Mar. 2022 (£6.60 Mil) to Mar. 2023 (£6.60 Mil) but then declined from Mar. 2023 (£6.60 Mil) to Mar. 2024 (£6.60 Mil).

Provexis Other Stockholders Equity Historical Data

The historical data trend for Provexis's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Provexis Other Stockholders Equity Chart

Provexis Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.60 6.60 6.60 6.60 6.60

Provexis Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.60 6.60 6.60 6.60 6.60

Provexis Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Provexis Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Provexis's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Provexis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Provexis PLC (LSE:PXS) » Definitions » Other Stockholders Equity
Comparable Companies
LSE:CEL LSE:N4P LSE:STX LSE:EAH ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS HKSE:03692 SZSE:000538 NBIX NSE:TORNTPHARM BOM:543904 BOM:500124
Traded in Other Exchanges
PXS.GB:UK
Address
2 Blagrave Street, I Ford, Reading, Berkshire, GBR, RG1 1AZ
Website
https://www.provexis.com
Provexis PLC is a British food company. It is engaged in developing and licensing the Fruitflow, which is patented, natural, breakthrough ingredient which helps with platelet aggregation. Fruitflow reduces the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can result in heart attack and stroke. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats.